News

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that ...
The History and Persistence of Our Deadliest Infection According to the World Health Organization, over 10 million people ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...
Researchers who have lost funds warned of long-term repercussions, but several said their school should still refuse to ...
An immunoblotting technique determined that the probe interacts with a specific receptor — a protein known as TREM2 — on ...
A laureate professor working on early diagnosis of ALS, or Amyotrophic Lateral Sclerosis, is one of several Harvard ...
The rhesus macaques were at risk of being prematurely euthanized after the $60 million research project, led in part by a Harvard scientist, was cut off from its NIH funding this week.
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...
A top scientist at Harvard who has spent years unraveling the mysteries of tuberculosis woke up Tuesday morning and ...
Projects that were stopped after Harvard rejected the government’s demands include a $60 million contract supporting an ...
Apr. 9, 2025 — This handheld device is the first that can detect tuberculosis in saliva, in addition to blood and sputum samples, an important breakthrough for testing children and HIV patients ...